News

Pfizer Stock Pops as Earnings Smash Expectations. Guidance Hiked in Face of Tariffs.
Second-quarter adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, beating expectations.
InvestorsHub on MSN35m
Pfizer lifts 2025 profit forecast after strong Q2 beats, shares rise
Pfizer (NYSE:PFE) raised its full-year earnings outlook on Tuesday after reporting second-quarter results that surpassed Wall ...
Earnings live: Palantir stock pops, Pfizer beats, Caterpillar warns of tariff impact
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Should You Buy Pfizer Stock Ahead of Its Q2 Results?
In terms of fundamentals, Pfizer currently boasts a market capitalization of $132 billion. Over the last twelve months, the company generated $62 billion in revenue and sustained operational ...
Pfizer: Earnings Meet Pressure (Rating Upgrade)
Pfizer's strong EPS surprise streak and positive earnings revisions are encouraging, but patent cliff risks remain a major ...
Pfizer (PFE) Reports Earnings Tomorrow: What To Expect
Global pharmaceutical company Pfizer (NYSE:PFE) will be announcing earnings results this Tuesday before market open. Here’s ...
Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 Earnings
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Nasdaq11mon
Is Pfizer Stock Ready to Bounce Back? - Nasdaq
Pharmaceutical giant Pfizer (NYSE: PFE) has been in a bit of a freefall since early 2022, with shares down by 46%. Pfizer's revenue and earnings dropped off a cliff along with its coronavirus ...
Pfizer raises 2025 profit forecast on cost cuts, forex gains
Pfizer raised its full-year profit forecast on Tuesday after topping Wall Street expectations for second-quarter results as ...